Clinical Trials Directory

Trials / Completed

CompletedNCT00102310

YM443 in Subjects With Functional Dyspepsia

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
416 (actual)
Sponsor
Astellas Pharma Inc · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study will be to characterize the dose response profile of YM443 in subjects with functional dyspepsia (FD) to enable the selection of doses for the Phase 3 clinical trial.

Conditions

Interventions

TypeNameDescription
DRUGYM443

Timeline

Start date
2004-03-10
Primary completion
2006-03-11
Completion
2006-03-11
First posted
2005-01-27
Last updated
2018-01-10

Locations

59 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00102310. Inclusion in this directory is not an endorsement.